-
Clinical Interventions in Aging
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Mild cognitive impairment: Conceptual, assessment, ethical, and social issues
Review
(2816) Views (707) Full article downloads
Authors: Perla Werner, Amos D Korczyn
Published Date September 2008
Volume 2008:3(3) Pages 413 - 420
DOI: http://dx.doi.org/10.2147/CIA.S1825
Perla Werner1, Amos D Korczyn2
1Department of Gerontology, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel; 2Sieratzki Chair of Neurology, Department of Neurology, Tel Aviv University, Ramat-Aviv, Israel
Abstract: Mild cognitive impairment (MCI) is defined as a condition characterized by newly acquired cognitive decline to an extent that is beyond that expected for age or educational background, yet not causing significant functional impairment. The concept of MCI has received considerable attention in the literature over the past few years, and aspects related to its definition, prevalence, and evolution have been extensively studied and reviewed. Here we attempt to synthesize the implications of the current status of this entity, focusing on the conceptual, methodological, and, in particular, the social and ethical aspects of MCI which have attracted less attention. We discuss the weaknesses of the concept of MCI, which is heterogeneous in etiology, manifestations, and outcomes, and suggest that the emergence of the syndrome at this stage reflects industrial interests related to possible development of drugs for this disorder. On the other hand, the formal diagnosis of MCI, with its implications that the person may develop dementia, may have a grave impact on the psychological state of the individual, at a stage when prediction of outcome is tenuous and possibilities of useful interventions are meager. We present suggestions for the direction of future research in these areas.
Keywords: mild cognitive impairment, assessment issues, ethical issues, social issues, dementia
Readers of this article also read:
The cognitive impact of anticholinergics: A clinical review
Moving towards implementation of a clinical ethics consultation program in Egyptian liver transplant units
Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma
Late onset Alzheimer’s disease in older people
Ethical issues in kidney transplantation – reflections from Nigeria
Clinical intervention in aging: ethicolegal issues in assessing risk and benefit
When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
Medical treatment and long-term outcome of chronic atrial fibrillation in the aged with chest distress: a retrospective analysis versus sinus rhythm
Correcting magnesium deficiencies may prolong life
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
- Eggshell membrane: A possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies
- Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation
- The cognitive impact of anticholinergics: A clinical review




